Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ziv-aflibercept in Eyes With Eyes With Retinal Diseases and Poor Vision-phase I

NCT02173873 is registered in ClinicalTrials.gov with Rafic Hariri University Hospital as lead sponsor.

NCT NCT02173873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02173873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ziv-aflibercept in Eyes With Eyes With Retinal Diseases and Poor Vision-phase I
Lead sponsor
Rafic Hariri University Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2014
Completion date
December 31, 2016
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, central retinal vein occlusion